Pharma Industry News

South Africa COVID-19 variant ‘unlikely’ to reduce efficacy of Pfizer/BioNTech jab

Lab study tested blood samples of vaccinated individuals against key virus mutations

Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]